QuantLogix ← ZBH scorecard
📅 ZBH Earnings Preview
Zimmer Biomet Holdings, Inc.
Next report (est.)
11/27/2026
Countdown
76 days
EPS growth YoY
+33.8%
Revenue growth YoY
+4.8%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±3.2% +2.5% over-priced
05/01/2026 ±5.4% +0.6% over-priced
11/05/2025 ±2.7% -15.2% under-priced
08/07/2025 ±2.2% +8.0% under-priced
05/05/2025 ±1.9% -11.6% under-priced
10/30/2024 ±1.6% +5.7% under-priced
08/07/2024 ±3.1% -3.4% under-priced
05/02/2024 ±2.0% -0.9% over-priced
Across these reports, options implied an average ±2.8% move vs an actual average of 6.0% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $1.03 $2.2B $200M
Q1 FY2026 $1.22 $2.1B $238M
Q4 FY2025 $0.71 $2.2B $138M
Q3 FY2025 $1.16 $2.0B $231M
Analyst posture
Buy / Strong Buy
11
Hold
22
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 77/100 Full scorecard →
Get alerted before every ZBH report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on ZBH before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Zimmer Biomet Holdings, Inc. (ZBH) reports in 76 days, with the next report estimated for 11/27/2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 6.0% on average — the market has been roughly fair on ZBH's earnings risk. Fundamentals into the print: EPS up 33.8% year-over-year, revenue up 4.8%. QuantLogix's live 5-factor engine currently reads ZBH as a buy at 77/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →